Altum Pharmaceuticals
  • About
    • History
    • Board of Directors
    • Management
    • Advisors
  • Disease Areas & Unmet Need
    • COVID-19
    • Cervical Dysplasia/Cancer and Human Papilloma Virus (HPV)
    • Cancer Bone Metastases & Skeletal Related Events
  • Pipeline
    • Pipeline Overview
    • AP-001
    • AP-002
    • AP-003
    • BiPhasix™ Platform
  • News & Events
  • Contact
Select Page

Altum Pharmaceuticals, Inc. completes acquisition of Lexi Pharma Inc, and its pipeline of novel therapies for bone disease and oncology

by MTECH Support | Apr 30, 2018 | Acquisition, Altum Pharmaceuticals, Business, Lexi Pharma

This acquisition: – Accelerates Altum’s vision to build a premier, global women’s health company – Incorporates Lexi’s experienced management team into Altum Pharmaceuticals – Strengthens Altum’s portfolio and strategic fit...

Recent Posts

  • Altum Pharma Appoints New Executive Chair of the Board of Directors
  • Altum Pharmaceuticals, Inc. completes acquisition of Lexi Pharma Inc, and its pipeline of novel therapies for bone disease and oncology
  • Altum Signs Exclusive Worldwide License Agreement
  • Altum Pharmaceuticals Enters into Agreement with Ortac Capital & Ortac AG

Archives

  • October 2018
  • April 2018
  • March 2017
  • June 2016
  • Privacy
  • Terms of Use
  • Cookie Policy
  • English
  • German
© 2020 Altum Pharmaceuticals Inc. All rights reserved.
We use cookies, including 3rd party cookies (e.g. Google, LinkedIn) to improve your experience on our website, analyse our traffic. By continuing to use this website, you accept our cookie policy.AcceptCookie policy